Not so benign intracranial hypertension
BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7390.613 (Published 22 March 2003) Cite this as: BMJ 2003;326:613Data supplement
Drugs associated with increased intracranial pressure (adapted from3 andw1) Vitamins or vitamin-like substances
Vitamin A
Multiple vitamins
Isotretinoin
Hormones
Corticosteroids (withdrawal)
Growth hormone
Danazol
Norplant
Chorionic gonadotrophin
Leuprolein
Oxytocin
Stanozol
Testosterone
Non-steroidal anti-inflammatory drugs
Ketoprofen, indomethacin in Bartter syndrome
Antibiotics
Tetracycline, minocycline, doxycycline
Nalidixic acid
Nitrofurantoin
Ciprofloxacin
Trimethoprim-sulfamethoxazole
Fluoroquinolones
Ofloxacin
Sulfonamides
Other drugs
Lithium
Amiodarone
Cimetidine
Phenytoin
Cyclosporin
Perhexiline maleate
Phenothiazine
Sinemet
Cytosine arabinoside
Nitroglycerin
w1 Schutta HS, Corbett JJ. Intracranial hypertension syndromes. In Joynt R, Griggs R, ed. Baker’s clinical neurology. Baltimore: Lippincott, Williams and Wilkins, 1997:1-57. (Ch 23 B.)
Related articles
- Clinical Review Published: 22 March 2003; BMJ 326 doi:10.1136/bmj.326.7390.641
See more
- Sixty seconds on . . . 10 000 stepsBMJ March 08, 2024, 384 q598; DOI: https://doi.org/10.1136/bmj.q598
- Scarlett McNally: Enabling active travel can improve the UK’s healthBMJ March 06, 2024, 384 q522; DOI: https://doi.org/10.1136/bmj.q522
- Scarlett McNally: Boosting swimming for health and joyBMJ February 20, 2024, 384 q393; DOI: https://doi.org/10.1136/bmj.q393
- Variability in blood pressure could help predict heart attack and stroke risk, researchers sayBMJ February 09, 2024, 384 q363; DOI: https://doi.org/10.1136/bmj.q363
- Scarlett McNally: Preventing obesity is different from curing it—and even more urgentBMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134